-

Butterfly Network to Present at the 42nd Annual Cowen Health Care Conference

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), today announced that it will participate in Cowen’s 42nd Annual Health Care Conference to be held virtually on March 7-9, 2022. Dr. Todd Fruchterman, President and CEO will participate in a virtual fireside chat on Wednesday, March 9, 2022, at 10:30 am Eastern Time.

A live webcast of the fireside chat and an archived recording will be available in the Events & Presentations section of the Butterfly Network investor website.

About Butterfly Network, Inc.

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world’s first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ and Butterfly iQ+ Vet can be purchased today by healthcare practitioners and veterinarians, respectively, in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only. For more information, visit www.butterflynetwork.com.

Contacts

Investors
Agnes Lee
650.677.9138
alee@butterflynetwork.com

Media
Holly Spring
781.888.8219
hspring@butterflynetwork.com

Butterfly Network, Inc.

NYSE:BFLY

Release Summary
Butterfly Network to Present at the 42nd Annual Cowen Health Care Conference
Release Versions
$Cashtags

Contacts

Investors
Agnes Lee
650.677.9138
alee@butterflynetwork.com

Media
Holly Spring
781.888.8219
hspring@butterflynetwork.com

More News From Butterfly Network, Inc.

Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report first quarter 2026 financial results on Thursday, April 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast...

Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women’s Health

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly,” “the Company”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated Gestational Age (GA) Tool integrated into its handheld ultrasound solution. This marks the first FDA-cleared blind-sweep ultrasound AI tool for estimating gestational age....

Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product...
Back to Newsroom